FDA Inspection 1341240 — Dr. Phillip Mathew, M.D.
The FDA completed an inspection of Dr. Phillip Mathew, M.D. on Oct 9, 2026 in Mississauga. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 9, 2026
- Fiscal Year
- 2027
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mississauga (Canada)
Additional Details
Clinical BA/BE